Get the Stockscreener App
0.3789
1.64%
0.0061
After Hours:
.38
0.0011
+0.29%
Autonomix Medical Inc stock is traded at $0.3789, with a volume of 76,950.
It is up +1.64% in the last 24 hours and down -3.95% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$0.3728
Open:
$0.3577
24h Volume:
76,950
Relative Volume:
0.49
Market Cap:
$4.32M
Revenue:
-
Net Income/Loss:
$-17.24M
P/E Ratio:
-0.0926
EPS:
-4.0935
Net Cash Flow:
$-11.91M
1W Performance:
+1.34%
1M Performance:
-3.95%
6M Performance:
-54.63%
1Y Performance:
-81.05%
1-Day Range:
$0.3577
$0.388
1-Week Range:
$0.3201
$0.3898
52-Week Range:
$0.3201
$2.6399
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
0.3789 | 4.25M | 0 | -17.24M | -11.91M | -4.0935 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Autonomix Medical Inc Stock (AMIX) Latest News
AMIX Stock Price, Quote & Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
Autonomix Medical Announces Abstract Acceptance At Digestive Disease Week 2026 - TradingView
Pancreatic cancer pain study from Autonomix lands DDW 2026 slot - Stock Titan
Autonomix (AMIX) Stock Factory Orders (+0.22%) 2026-04-27Insider Selling - Newser
Autonomix (AMIX) Innovation Pipeline | Autonomix Medical posts narrower loss with 39.7% EPS surpriseATM Offering - Cổng thông tin điện tử Tỉnh Sơn La
Autonomix Medical shares rally on positive pancreatic cancer pain data - MSN
Is Autonomix (AMIX) stock cyclical or defensive | Q1 2026: EPS Exceeds ExpectationsMost Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Autonomix Medical, Inc. to Present Long-Term Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at ECIO 2026 - Quiver Quantitative
Long-term pancreatic cancer pain study from Autonomix gets Basel stage - Stock Titan
Autonomix (AMIX) Stock: Forming Reversal? (-1.97%) 2026-04-20Risk Management - Xã Thanh Hà
Insider Trends: Can Autonomix Medical Inc scale operations efficiently2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
Insider Sell: What analysts say about Autonomix Medical Inc stockStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Autonomix Medical Inc meet Warren Buffetts criteria2026 Institutional Moves & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Jobs Data: Is Autonomix Medical Inc a potential multi bagger2026 Market Trends & High Return Stock Watch Alerts - baoquankhu1.vn
Autonomix Medical’s Featured Abstract on Pain Mitigation in Pancreatic Adenocarcinoma to be Presented at SIR 2026 Annual Scientific Meeting - Quiver Quantitative
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 - Weekly Voice
Autonomix Medical Selected for Featured Abstract and Podium - GlobeNewswire
Whale Trades: What are analysts price targets for Autonomix Medical IncAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Is Autonomix (AMIX) Stock Slowing Down | Price at $0.39, Down 1.14%Sell Signals - Newser
Market Outlook: How is Autonomix Medical Inc managing supply chain issues2026 Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
AMIX Stock Analysis: Autonomix Medical Inc. medtech stock at 0.4 gains 3.18 pct - Newser
Aug Big Picture: Is Autonomix Medical Inc a speculative investment2026 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn
RSI Check: What analysts say about Autonomix Medical Inc stockQuarterly Risk Review & Safe Entry Point Identification - baoquankhu1.vn
Meme Stocks: Is Autonomix Medical Inc a potential multi bagger2026 Winners & Losers & Low Risk High Win Rate Picks - baoquankhu1.vn
Autonomix Medical, Inc.: Fundamental Analysis and Financial Ratings | AMIX | US05330T2050 - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Market Review: Is Autonomix Medical Inc a speculative investmentOptions Play & Technical Buy Zone Confirmation - baoquankhu1.vn
Hedge Fund Bets: Does Autonomix Medical Inc have a sustainable dividendQuarterly Profit Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Autonomix Medical (AMIX) Stock Price, News & Analysis - MarketBeat
Forecast Cut: Is Autonomix Medical Inc a speculative investment2026 Buyback Activity & Smart Investment Allocation Insights - baoquankhu1.vn
Autonomix Medical to Present at LSI USA '26 - marketscreener.com
Autonomix Medical to Present at LSI USA '26 Conference on Innovative Nerve-Targeted Treatments - Quiver Quantitative
Autonomix Medical to Present at LSI USA ’26 - GlobeNewswire
Medtech summit talk: Autonomix CEO on stage at LSI USA ’26 - Stock Titan
How is Autonomix Medical Inc managing supply chain issues2026 Bull vs Bear & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - The Globe and Mail
Autonomix Medical, Inc. Secures Oral Presentation Spot at CRT 2026 for Innovative Nerve-Targeted Technology - Quiver Quantitative
New nerve-targeting tech lands CRT 2026 Best Innovation stage - Stock Titan
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis - Bitget
Autonomix Medical Selected as Top Abstract at CRT 2026 and - GlobeNewswire
Quarterly Trades: What analysts say about Autonomix Medical Inc stockPortfolio Update Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Autonomix Medical to Present Long-Term Pain Data for Pancreatic Cancer at SSO 2026 - National Today
AMIX Should I Buy - Intellectia AI
Autonomix Medical Launches CEO Corner to Highlight Peer-Reviewed Publication Strategy and Scientific Validation Efforts - geneonline.com
Autonomix Medical Announces Release Of New CEO Corner Segment - TradingView
Autonomix CEO on validating nerve-targeting tech through peer review - Stock Titan
Autonomix Medical Announces Release of New CEO Corner - GlobeNewswire
AMIXAutonomix Medical Inc Latest Stock News & Market Updates - Stock Titan
Is Autonomix Medical Inc. forming a breakout patternJuly 2025 Recap & Low Risk High Win Rate Picks - mfd.ru
Autonomix Medical Selected to Present New Long-Term Pain - GlobeNewswire
Autonomix Medical (NASDAQ:AMIX) Given New $2.00 Price Target at Maxim Group - Defense World
Autonomix Medical Inc Stock (AMIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):